<p>(a) Indicated agents were treated for 5 min and 5 µM concentration with or without 30 min pre-incubation of 2.5 µM concentration of STO609 in L6 myotubes. (b) L6 myotubes was transfected by mock or two different LKB1 siRNA for 48 h. After infection, indicated agents were treated for 5 min and 5 µM concentration. The graphs show quantification of western blot based on densitometric analysis. (c) Indicated agents were treated for 5 min and 5 µM concentration to L6 myotubes. Celluar AMP/ATP ratio was measured by high-performance liquid chromatography as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0108771#s2" target="_blank">Materials and Methods</a>. Western blot data represent one of three independent...
<p>Ncls treatment led to (A) increased phospho-AMPKα (pAMPKα), increased phospho-ACC2 (pACC2), and (...
<p>*p < 0.05, compared with control. **p < 0.05, compared with DBM-treated cells. (B) L6 myotubes we...
<p>A: Myotubes were treated with 2 mmol/l CGA for various incubation periods up to 24 hours. B: Myot...
<p>L6 myotubes were starved for 2 hours in serum free high glucose DMEM containing 0.2%BSA followed ...
<p>(a) L6 myotubes were pre-incubated with the AMPK chemical inhibitor, compound c, for 30 min and t...
<p>Differentiated C2C12 cells (A) were transfected with LKB1 siRNA for 24 h. Two different fields of...
<p>(A) Differentiated L6 cells were treated with MES (0.1 ms, 1 V/cm, 55 pps) for 10 min. Cell lysat...
<p>L6 myotubes were transfected with vehicle, unrelated siRNA or AMPKα1/2 siRNA as described in Rese...
<p>(A) C2C12 cells were infected with either shRNA encoding for a non-target or LKB1 sequences and d...
<p>Serum-starved HeLa cells (<b>A–C</b>) or L6 myotubes (<b>D–F</b>) were pre-treated ±1 µM STO-609 ...
<p>The xanthene derivatives Xn (a), Xc (b) and metformin (c) increased phosphorylation of AMPK<i>a</...
<p><b>A</b> AMPK Thr<sup>172</sup>-phosphorylation in L6 myoblast after stimulation with 1μM compoun...
<p>A) HCC366, H322, and A549 were transfected with TUSC2 then either treated with 1 µM MK2206 for 24...
<p>(A) Densitometric analysis (top) and representative western blot (bottom) of pAMPK/total AMPK in ...
<p>This is a representative blot from three individual experiments. The density of the bands were qu...
<p>Ncls treatment led to (A) increased phospho-AMPKα (pAMPKα), increased phospho-ACC2 (pACC2), and (...
<p>*p < 0.05, compared with control. **p < 0.05, compared with DBM-treated cells. (B) L6 myotubes we...
<p>A: Myotubes were treated with 2 mmol/l CGA for various incubation periods up to 24 hours. B: Myot...
<p>L6 myotubes were starved for 2 hours in serum free high glucose DMEM containing 0.2%BSA followed ...
<p>(a) L6 myotubes were pre-incubated with the AMPK chemical inhibitor, compound c, for 30 min and t...
<p>Differentiated C2C12 cells (A) were transfected with LKB1 siRNA for 24 h. Two different fields of...
<p>(A) Differentiated L6 cells were treated with MES (0.1 ms, 1 V/cm, 55 pps) for 10 min. Cell lysat...
<p>L6 myotubes were transfected with vehicle, unrelated siRNA or AMPKα1/2 siRNA as described in Rese...
<p>(A) C2C12 cells were infected with either shRNA encoding for a non-target or LKB1 sequences and d...
<p>Serum-starved HeLa cells (<b>A–C</b>) or L6 myotubes (<b>D–F</b>) were pre-treated ±1 µM STO-609 ...
<p>The xanthene derivatives Xn (a), Xc (b) and metformin (c) increased phosphorylation of AMPK<i>a</...
<p><b>A</b> AMPK Thr<sup>172</sup>-phosphorylation in L6 myoblast after stimulation with 1μM compoun...
<p>A) HCC366, H322, and A549 were transfected with TUSC2 then either treated with 1 µM MK2206 for 24...
<p>(A) Densitometric analysis (top) and representative western blot (bottom) of pAMPK/total AMPK in ...
<p>This is a representative blot from three individual experiments. The density of the bands were qu...
<p>Ncls treatment led to (A) increased phospho-AMPKα (pAMPKα), increased phospho-ACC2 (pACC2), and (...
<p>*p < 0.05, compared with control. **p < 0.05, compared with DBM-treated cells. (B) L6 myotubes we...
<p>A: Myotubes were treated with 2 mmol/l CGA for various incubation periods up to 24 hours. B: Myot...